
First-in-Class RNA Degrader Targets Historically "Undruggable" MYC in Preclinical Multiple Myeloma Models
<a href="https://news.google.com/rss/articles/CBMi1AFBVV95cUxNdURrQ1lJaEdZRzA0U3NJd0NSRDVGTTBjYUtxQmY5NUUteEdCMGtwNG5kRUttRkdvUzdENFVtQ0RLTl9fUTg1aDFPckpSNmpYYkNvdk55WFBROGxTdlRkdGJGeW9nTmZTd1ZybHZGanE4UE1WUkxuQWlqSW9wLURocExibk9hU0dXMWN1SEgtVHdpWkIzYUVTUlNLbU1iRkxWT1hwc01UQU12bWNub3p1SDVXMmluUVZvN2pjSzBRTmV4NVY4bGdXeEhXX2l4MmpFWnVoSQ?oc=5" target="_blank">First-in-Class RNA Degrader Targets Historically "Undruggable" MYC in Preclinical Multiple Myeloma Models</a>&nbsp;&nbsp;<font color="#6f6f6f">Pharmacy Times</font>